XML 409 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Revenue $ 5,700,199 $ 76,995
Cost of revenue 7,641,684 1,590,636
Gross loss (1,941,485) (1,513,641)
Operating expenses    
Research and development 1,179,944 114,873
General and administrative 10,892,443 4,720,824
Total operating expenses 12,072,387 4,835,697
Loss from operations (14,013,872) (6,349,338)
Other (expense) income    
Change in valuation of warrant derivative liabilities 964,124
Change in valuation of embedded derivative liabilities (2,971,694) 64,614
True-up termination fee (1,344,648)
Settlement of promissory notes receivable (3,366,031)
Interest expense (2,508,874)
Interest income 22,262 411
Liquidated damages (2,940,654)
Other income (129)
Total other (expense) income (12,145,644) 65,025
Loss before income taxes (26,159,516) (6,284,313)
Benefit for income taxes 91,633
Net loss (26,067,883) (6,284,313)
Deemed dividend on Series H convertible preferred stock (18,045,496)
Net loss attributable to common shareholders $ (44,113,379) $ (6,284,313)
Basic and diluted net loss per common share $ (1.69) $ (0.42)
Weighted average number of common shares outstanding - basic and diluted 26,128,796 14,919,232